SynHelix logo — Demand for synthetic DNA is growing rapidly in biotech indus...

SynHelix

Demand for synthetic DNA is growing rapidly in biotech industry, and SynHelix aims to meet supply needs.

Founded 2019 France France 11-50 employees Biotechnology

General Information

Company Name SynHelix
Founded Year 2019
Location France France +1
Employees 11-50
Industries Biotechnology
Social

Get notified when SynHelix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SynHelix

SynHelix is a biotech startup based in France, founded in 2019, that has identified a significant market opportunity in the rapidly growing demand for synthetic DNA in fields such as synthetic biology, gene therapy, and diagnostics. The company aims to address the current supply bottleneck faced by the pharma and biotech industry by offering DNA constructs with higher purity and a yield 10,000 times greater than existing options. The market for synthetic DNA is expected to boom in the coming years, and SynHelix is strategically positioned to meet the supply needs within this industry. The company is actively seeking exceptional scientists and executives to join their team in the mission of creating an exciting synthetic biology platform. This presents an opportunity for professionals who are passionate about cutting-edge research and aspire to make a difference in tackling modern challenges. At present, there is no available information regarding investments or investors in SynHelix. However, given the potential of the biotech industry and the increasing demand for synthetic DNA, this startup may attract attention from venture capital firms looking to invest in disruptive technologies that address critical industry needs. SynHelix's mission aligns with the growing interest in synthetic biology, making it a potential target for future investment opportunities.

Taxonomy: Synthetic Biology, DNA Constructs, Molecular Biology, Gene Synthesis, Gene Therapy, Biotherapeutics, Protein Engineering, Recombinant Proteins, Biochemistry, Enzymology, Computational Biology, Cell Therapy, Nanotechnology

No funding data available for SynHelix yet.

Get notified when SynHelix raises funding

SynHelix Alternatives & Competitors

SynHelix vs
RootPath
RootPath United States

Enabling biology at scale

Series B
5 employees
Biotechnology
SynHelix vs

DNA Synthesis Uncompromised

Series B
4 employees
Biotechnology, Health Care
SynHelix vs
Evonetix Ltd
Evonetix Ltd United Kingdom

Technology to ignite the biology revolution

Series B
11 employees
Biopharma, Biotechnology

FAQ About SynHelix

Demand for synthetic DNA is growing rapidly in biotech industry, and SynHelix aims to meet supply needs.
SynHelix was founded in 2019.
SynHelix is headquartered in France.
SynHelix operates in the following industries: Biotechnology.
SynHelix has approximately 11-50 employees.
Top alternatives and competitors to SynHelix include RootPath, Molecular Assemblies, Inc., Evonetix Ltd, Gen9 Genetics, De Novo DNA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SynHelix and RootPath are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SynHelix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy